Café

© 2026 Longbridge｜Terms of Service Privacy Policy

ZHIFEI-BIOL: CA111 injection has entered Phase I clinical trials

ZHIFEI-BIOL: CA111 injection has entered Phase I clinical trials

Wallstreetcn

Jan 12, 2026 at 04:35 AM

ZHIFEI-BIOL: CA111 injection enters Phase I clinical trial

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

ZHIFEI-BIOL

300122.SZ

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI